Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians.
about
Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unitGlobal characteristics of childhood acute promyelocytic leukemia.Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports.
P2860
Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@en
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@nl
type
label
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@en
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@nl
prefLabel
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@en
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@nl
P2860
P1476
Molecular diagnosis and risk-a ...... s: a primer for pediatricians.
@en
P2093
Judith Frances Margolin
P2860
P2888
P304
P356
10.1007/S00431-011-1424-7
P577
2011-02-25T00:00:00Z